PPT-WNT5A and Breast Cancer Group 1:

Author : calandra-battersby | Published Date : 2019-03-05

Matthew Beatty Brynn Cullander Melissa Frank Justin Ludwig Mosharaf Mahmud Syed Andrew Pierce and Ashton Sigler History Discovered in the 1984 by Roel Nusse and

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "WNT5A and Breast Cancer Group 1:" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

WNT5A and Breast Cancer Group 1:: Transcript


Matthew Beatty Brynn Cullander Melissa Frank Justin Ludwig Mosharaf Mahmud Syed Andrew Pierce and Ashton Sigler History Discovered in the 1984 by Roel Nusse and Harold Varmus as the int1 gene. nbcamorg reast cancer is the second most common kind of cancer in women About 1 in 8 women born today in the United States will get breast cancer at some point The good news is that many women can survive breast cancer if its found and treated earl DR. A. AKHATOR FWACS, FICS. SENIOR LECTURER DELSU . CONSULTANT SURGEON DELSUTH. PRE-TEST. Breast cancer is the most common cancer in women in Nigeria . Breast cancer is the most common cause of cancer related deaths. The Obstetrics & Gynecological Society of Bhopal. &. AMPOGS . Research Public Welfare Society. Screening tools. Clinical Breast examination. Breast self examination. Mammography. Ultrasonography/. Kristin . DePrince. Mattie, M.S.. Licensed / Certified Genetic Counselor. William G. Rohrer Cancer Genetics Program. Objectives. Describe . current approaches to genetic testing for hereditary cancer syndromes. Susan M. Domchek, MD. Basser Professor of Oncology. University of Pennsylvania . Sex. Age. Family . history. Depends on specific of family history. Depends on whether there is a k. nown . genetic . susceptibility. Rachna Raman MD MS. Hematology and Medical Oncology. Bon Secours Cancer Institute at St. Mary’s Hospital. Objectives. Risk factors . Screening guidelines and controversies. Screening and management of patients at high risk for breast cancer. Inspection. Size. S. ymmetry (some variation is normal) . Shape. Contour (flattening, masses, and dimpling). S. kin (color, edema, rashes, thickening, and venous pattern). S. cars (previous surgery, injuries). {Template Slide Set}. 1. Overview. What are Hereditary Breast and Ovarian Cancer syndrome (HBOC) and Lynch . s. yndrome (LS)?. How common are LS and HBOC? . How do LS and HBOC affect individuals and families?. BRCA2 is a tumor suppressor gene responsible for DNA repair . BRCA2 was discovered in breast cancer tumors of patients without BRCA1 mutations. Mice knockouts discovered that BRCA2 is directly involved in double strand break repair. Julie R. Gralow, M.D.. Director, Breast Medical Oncology. Jill Bennett Endowed Professor of Breast Cancer. Professor, Global Health. University of Washington School of Medicine. Fred Hutchinson Cancer Research Center. Alexis Clark. 1. . and Rebecca Haberman. 1. 1. Dept. of Biology, Mary Baldwin University, Staunton, VA. Introduction. . In the United States alone 1 in 8 women will develop invasive breast cancer over the course of their lifetime(1).. group. of diseases. . All forms of cancer cause cells in the body to change and grow out of control. . Most types of cancer cells form a lump or mass called a . tumor. . . The tumor can invade and destroy healthy tissue. Cells from the tumor can break away and travel to other parts of the body. There they can continue to grow. . March 2019. Preview/Introduction. The Risk of Breast Cancer to Women. Does Mammography Save Lives?. When to Start and How Often Should Women Screen?. Risks Versus Benefits of Mammography. Breast Cancer: The Impact on Women. Azeez Farooki, MD. Attending Physician, Clinical Member. Memorial Sloan Kettering Cancer Center. New York, NY. Objectives. Elucidate the problem of aromatase inhibitor induced bone loss and increased risk of fractures in breast cancer.

Download Document

Here is the link to download the presentation.
"WNT5A and Breast Cancer Group 1:"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents